Welcome
PPM

Abstract

 
  Search

 


 

 

 






Protecting Pain Physicians from Legal Challenges: Part 2

by Forest Tennant, MD, DrPH

 The landscape for risk in pain treatment is rapidly changing. Heretofore, physicians have been reluctant to prescribe opioids for chronic pain treatment due to fear of prosecution by State Medical Boards and the Federal Drug Enforcement Agency (DEA). Due to pressure from a public that demands opioid drugs for pain treatment, most states, however, have now adopted laws, regulations, and guidelines that allow a physician to treat chronic pain without fear of retribution. Risk of malpractice is, however, replacing the risk of government prosecution as the physician’s cross-to-bear. In this decade, a variety of mal-practice suits have befallen physicians who have attempted to treat chronic pain with opioid drugs. In the last issue of Practical Pain Management, we focused on the problem of sudden, unexpected deaths in pain patients and the misinterpretation of their opioid blood levels. In this second article we wish to highlight other legal challenges that have come to our attention. In addition to unexpected deaths we are aware of legal challenges involving undertreatment, withdrawal from opioids while pain is still present, and complications of severe chronic pain (see Table 1). Not discussed here are legal challenges that may result from billing practices or invasive interventions.

Table 1. Malpractice Challenges for Physicians

  1. Sudden, unexpected death in a pain patient.
  2. Undertreatment or opioid withdrawal and failure to prevent pain flares.
  3. Complications of severe, chronic pain such as dementia, infection, or cardiovascular events.

A ten-point malpractice-prevention program is presented to avoid risk and protect against legal challenges. Selected cases are then presented to emphasize that all could have been prevented in a medical practice.

Ten-Point Malpractice Prevention Plan
This plan is designed for the busy practitioner who may have limited time to spend with each patient (see Table 2). Futhermore, it doesn’t depend upon expensive laboratory tests, consultations, or large office staff. Due to the high pre-valence of chronic pain in the general population, it is well recognized that chronic pain treatment with opioid drugs must be done. Treatment must necessarily take place in busy practice settings throughout rural and urban areas of America. Put another way, this ten-point plan can be done in a two-person office, and the author believes that the implementation of these points either prevented or would have prevented all the malpractice suits personally reviewed.

Please refer to the April 2008 issue for the complete text. In the event you need to order a back issue, please click here.

— April 2008

The full article is now available as a PDF and may be
purchased for $5 and downloaded immediately:
Order Now


©2007 Copyright. PPM Communications, Inc. All rights reserved.